Endocrinology News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–5 of 5 articles
Earlier
High impact NewsJun 8, 2026
Neurocrine Biosciences pipeline update: what analysts should watch next
neurology · 7 min
Dr. Sarah MitchellHigh impact NewsMay 4, 2026
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen in McCune-Albright Syndrome
FDA · 2 min
James Chen, PharmDCritical impact NewsMay 2, 2026
Neurocrine Biosciences CRENESSITY Shows Sustained Benefits in Two-Year Pediatric CAH Study
2 min
Dr. Priya NandakumarHigh impact NewsApr 25, 2026
FDA Encourages Testosterone Therapy Expansion for Low Libido in Men with Hypogonadism
FDA · 3 min
Dr. Sarah MitchellHigh impact NewsApr 14, 2026
FDA Approves Biosimilar Insulin Lispro: What You Need to Know
FDA · Diabetes Mellitus · 4 min
Dr. Sarah MitchellExplore intelligence